No Data
No Data
Evolent Health's Promising Financial Outlook Justifies Buy Rating
Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks
JMP Securities Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $13
JMP Securities Reiterates Market Outperform on Evolent Health, Maintains $13 Price Target
Express News | Evolent Names Shawn Guertin as New Independent Nominee for Election to Its Board of Directors
TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $14
151798759 OP : sonething is up… fingers crossed